⌘K

Login Start Free

Home/Filings/4/0001144204-15-050720

4//SEC Filing

Arch Therapeutics, Inc. 4

Accession 0001144204-15-050720

CIK 0001537561operating

View on SEC.gov Company Profile

Filed

Aug 18, 8:00 PM ET

Accepted

Aug 19, 4:07 PM ET

Size

5.3 KB

Accession

0001144204-15-050720

Insider Transaction Report

Form 4

Period: 2015-08-18

Arch Therapeutics, Inc.ARTH

DAVIS RICHARD E

CFO & TREASURER

Transactions

Award
Stock Option (right to buy)
2015-08-18+175,000→ 175,000 total
Exercise: $0.28Exp: 2025-08-17→ Common Stock (175,000 underlying)

Footnotes (1)

[F1]Of the Shares subject to the Option, 25% shall vest immediately upon August 18, 2015, and 1/36 of the remaining unvested Shares subject to the Option shall vest on each of the next thirty-six (36) monthly anniversaries.

Documents

1 file

4
v418648_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Arch Therapeutics, Inc.

CIK 0001537561

Entity typeoperating

IncorporatedNV

Related Parties

1

filerCIK 0001537561

Filing Metadata

Form type: 4
Filed: Aug 18, 8:00 PM ET
Accepted: Aug 19, 4:07 PM ET
Size: 5.3 KB

View on SEC.gov